Gå direkte til indholdet

Onkologi (pædiatri)

Individualiseret/modificeret kemoterapi (udsættelse og/eller ændring af dosis)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (åbner nyt vindue)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Kilde‎: N Engl J Med 1998;338(8):499-505.

Indekseret‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (åbner nyt vindue)

Childhood cancer and the Jehovah's Witness faith. (åbner nyt vindue)

Frankel LS, Damme CJ, Eys JV.

Kilde‎: Pediatrics 1977;60(6):916-21.

Indekseret‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (åbner nyt vindue)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (åbner nyt vindue)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Kilde‎: J Clin Oncol 2004;22(24):4888-92.

Indekseret‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (åbner nyt vindue)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (åbner nyt vindue)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Kilde‎: JAMA Oncol 2022;8(1):79-87. 

Indekseret‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (åbner nyt vindue)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (åbner nyt vindue)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Kilde‎: Haematologica 2000;85(11):1221-2.

Indekseret‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (åbner nyt vindue)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (åbner nyt vindue)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Kilde‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indekseret‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (åbner nyt vindue)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (åbner nyt vindue)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Kilde‎: Bone Marrow Transplant 2003;32(4):433-6.

Indekseret‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (åbner nyt vindue)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (åbner nyt vindue)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Kilde‎: Bone Marrow Transplant 2005;36(8):715-20.

Indekseret‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (åbner nyt vindue)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (åbner nyt vindue)

Zwaan CM, Kaspers GJ

Kilde‎: Br J Haematol 2004;127(3):264-79.

Indekseret‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (åbner nyt vindue)